Drug
Abiprubart
Abiprubart: highest development phase Phase 2, developed by Kiniksa Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Kiniksa Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Abiprubart NCT06531395 | Phase 2 | Sjögrens Disease |
Latest
No recent events.
Follow Abiprubart on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.